P. Ruas-Madiedo
Consejo Superior de Investigaciones Científicas
PATRICIA RUAS-MADIEDO: Ph.D. Biology in 1999, postdoctoral at NIZO Food Research (The Netherlands, 1999-2002) and since 2003 working in the Dairy Research Institute of Asturias belonging to the Spanish National Research Council (IPLA-CSIC). Member of the CSIC staff scientists in 2006 and leader of several research projects. The keywords describing my research lines are microbiology, exopolysaccharides, probiotics, prebiotics, functional foods, dairy products technology and, more recently, probiotic-host interactions and immunology. Research lines: i) microbial physiology, probiotics, Bifidobacterium, exopolysaccharides, prebiotics; ii) host-bacteria interactions, cell lines, immunology, intestinal absorption models; iii) probiotic antagonism against intestinal and foodborne pathogens upon the host; iv) functional foods, dairy technology, physic-chemical characterization, micro- and macrostructure dairy matrix.
- Papers in database
- 22
- Years active
- 2007 – 2023
- Total publications
- 257
- Total citations
- 14,058
- h-index
- 62
- Health outcomes studied
- 3
Research Areas
- Probiotics and Fermented Foods
- Gut microbiota and health
- Microbial Metabolites in Food Biotechnology
- Clostridium difficile and Clostridium perfringens research
- Enzyme Production and Characterization
Health Outcomes Studied
Papers (22)
- 2023Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice10.1128/spectrum.05063-22
- 2020Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA10.1038/s41598-020-70986-z
- 2020Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective10.3390/microorganisms8050723
- 2020Bifidobacteriumlongum subsp. infantis CECT7210 (B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens10.3390/nu12113259
- 2017Bifidobacteria and Their Molecular Communication with the Immune System10.3389/fmicb.2017.02345
- 2017Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum.10.1016/j.carbpol.2017.07.039
- 2017In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.10.1016/j.ijfoodmicro.2016.11.011
- 2017Bifidobacteria and Their Health-Promoting Effects.10.1128/microbiolspec.BAD-0010-2016
- 2016Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates10.3389/fmicb.2016.00738
- 2016Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model10.3389/fmicb.2016.00868
- 2015Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis10.3389/fmicb.2014.00766
- 2014Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression.10.1016/j.ijfoodmicro.2014.02.024
- 2014Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue.10.1016/j.anaerobe.2014.01.003
- 2013Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010.10.1016/j.anaerobe.2013.03.003
- 2013Interactions between Bifidobacterium and Bacteroides Species in Cofermentations Are Affected by Carbon Sources, Including Exopolysaccharides Produced by Bifidobacteria10.1128/AEM.02545-13
- 2012Characterization of exopolysaccharides produced by Bifidobacterium longum NB667 and its cholate-resistant derivative strain IPLA B667dCo.10.1021/jf204034n
- 2012Complete Genome Sequence of Streptococcus salivarius PS4, a Strain Isolated from Human Milk10.1128/JB.00896-12
- 2011Technological characterization and survival of the exopolysaccharide-producing strain Lactobacillus delbrueckii subsp. lactis 193 and its bile-resistant derivative 193+ in simulated gastric and intestinal juices.10.1017/S0022029911000355
- 2011Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.10.1016/j.ijfoodmicro.2010.10.016
- 2010Inside the adaptation process of Lactobacillus delbrueckii subsp. lactis to bile.10.1016/j.ijfoodmicro.2010.06.013
- 2009Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.10.1016/j.ijfoodmicro.2009.08.017
- 2007Cell envelope changes in Bifidobacterium animalis ssp. lactis as a response to bile.10.1111/J.1574-6968.2007.00854.X